Compare ACNB & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ACNB | YDES |
|---|---|---|
| Founded | 1857 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.5M | 543.0M |
| IPO Year | 1994 | N/A |
| Metric | ACNB | YDES |
|---|---|---|
| Price | $60.84 | $2.47 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $58.00 | N/A |
| AVG Volume (30 Days) | 71.9K | ★ 344.1K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $191,821,000.00 | N/A |
| Revenue This Year | $13.18 | N/A |
| Revenue Next Year | $1.91 | N/A |
| P/E Ratio | $46.85 | ★ N/A |
| Revenue Growth | ★ 45.10 | N/A |
| 52 Week Low | $41.03 | $1.70 |
| 52 Week High | $62.07 | $25.00 |
| Indicator | ACNB | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 59.12 | 46.64 |
| Support Level | $48.10 | $2.14 |
| Resistance Level | $61.73 | $3.05 |
| Average True Range (ATR) | 1.38 | 0.41 |
| MACD | -0.04 | 0.11 |
| Stochastic Oscillator | 63.39 | 57.04 |
ACNB Corp is the financial holding company. Through its wholly-owned subsidiaries, it provides a full range of retail and commercial financial services in Pennsylvania and Maryland through its network of community banking offices. It also provides property, casualty, health, life and disability insurance serving personal and commercial clients through offices in Westminster, Maryland, and Gettysburg, Pennsylvania and is licensed to do business. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage; and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.